Global and Europe CAR T-cell Therapy Market Professional Survey Report 2019

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Global CAR T-cell Therapy market was valued at XX.0 million US$ in 2018, with the CAGR of 4.8%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe CAR T-cell Therapy market. Describe product range of CAR T-cell Therapy, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe CAR T-cell Therapy market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe CAR T-cell Therapy market.

     

    By Player

    • Legend Biotech

    • Pfizer, Inc.

    • Celyad, Inc.

    • Bluebird Bio, Inc.

    • Aurora BioPharma, Ltd.

    • Kite Pharma, Inc.

    • Celgene (Juno Therapeutics) Inc.

    • Juno Therapeutics

    • Aurora BioPharma, Ltd.

    • Aurora Biopharma Inc.

    • Allogene Therapeutics International AGech

    • Bluebird Bio, Inc.

    By Type

    • CD 19

    • CD 20

    • CD22

    • CD30

    • CD33

    • HER1

    • HER2

    • Meso

    • Egfrvlll

    By End-User

    • Acute Lymphocytic Leukemia

    • Chronic Lymphocytic Leukemia

    • Non Hodgkin Leukemia

    • Multiple Myeloma

    • Pancreatic Cancer

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of CAR T-cell Therapy Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global CAR T-cell Therapy Market Size and Growth Rate of CD 19 from 2014 to 2026

      • 1.3.2 Global CAR T-cell Therapy Market Size and Growth Rate of CD 20 from 2014 to 2026

      • 1.3.3 Global CAR T-cell Therapy Market Size and Growth Rate of CD22 from 2014 to 2026

      • 1.3.4 Global CAR T-cell Therapy Market Size and Growth Rate of CD30 from 2014 to 2026

      • 1.3.5 Global CAR T-cell Therapy Market Size and Growth Rate of CD33 from 2014 to 2026

      • 1.3.6 Global CAR T-cell Therapy Market Size and Growth Rate of HER1 from 2014 to 2026

      • 1.3.7 Global CAR T-cell Therapy Market Size and Growth Rate of HER2 from 2014 to 2026

      • 1.3.8 Global CAR T-cell Therapy Market Size and Growth Rate of Meso from 2014 to 2026

      • 1.3.9 Global CAR T-cell Therapy Market Size and Growth Rate of Egfrvlll from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global CAR T-cell Therapy Market Size and Growth Rate of Acute Lymphocytic Leukemia from 2014 to 2026

      • 1.4.2 Global CAR T-cell Therapy Market Size and Growth Rate of Chronic Lymphocytic Leukemia from 2014 to 2026

      • 1.4.3 Global CAR T-cell Therapy Market Size and Growth Rate of Non Hodgkin Leukemia from 2014 to 2026

      • 1.4.4 Global CAR T-cell Therapy Market Size and Growth Rate of Multiple Myeloma from 2014 to 2026

      • 1.4.5 Global CAR T-cell Therapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of CAR T-cell Therapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of CAR T-cell Therapy by Major Types

      • 3.4.1 Market Size and Growth Rate of CD 19

      • 3.4.2 Market Size and Growth Rate of CD 20

      • 3.4.3 Market Size and Growth Rate of CD22

      • 3.4.4 Market Size and Growth Rate of CD30

      • 3.4.5 Market Size and Growth Rate of CD33

      • 3.4.6 Market Size and Growth Rate of HER1

      • 3.4.7 Market Size and Growth Rate of HER2

      • 3.4.8 Market Size and Growth Rate of Meso

      • 3.4.9 Market Size and Growth Rate of Egfrvlll

    4 Segmentation of CAR T-cell Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of CAR T-cell Therapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of CAR T-cell Therapy for Acute Lymphocytic Leukemia

      • 4.4.2 Market Size and Growth Rate of CAR T-cell Therapy for Chronic Lymphocytic Leukemia

      • 4.4.3 Market Size and Growth Rate of CAR T-cell Therapy for Non Hodgkin Leukemia

      • 4.4.4 Market Size and Growth Rate of CAR T-cell Therapy for Multiple Myeloma

      • 4.4.5 Market Size and Growth Rate of CAR T-cell Therapy for Pancreatic Cancer

    5 Market Analysis by Major Regions

    • 5.1 Global CAR T-cell Therapy Production Analysis by Top Regions

    • 5.2 Global CAR T-cell Therapy Consumption Analysis by Top Regions

    • 5.3 Global CAR T-cell Therapy Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America CAR T-cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe CAR T-cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific CAR T-cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA CAR T-cell Therapy Production, Import, Consumption and Export Analysis

    6 Product Circulation of CAR T-cell Therapy Market among Top Countries

    • 6.1 Top 5 Export Countries in CAR T-cell Therapy Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in CAR T-cell Therapy Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in CAR T-cell Therapy Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in CAR T-cell Therapy Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in CAR T-cell Therapy Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in CAR T-cell Therapy Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America CAR T-cell Therapy Landscape Analysis

    • 7.1 North America CAR T-cell Therapy Landscape Analysis by Top Countries

      • 7.1.1 United States CAR T-cell Therapy Market Volume and Growth Rate

      • 7.1.2 Canada CAR T-cell Therapy Market Volume and Growth Rate

      • 7.1.3 Mexico CAR T-cell Therapy Market Volume and Growth Rate

    8. Europe CAR T-cell Therapy Landscape Analysis

    • 8.1 Europe CAR T-cell Therapy Landscape Analysis by Major Types

    • 8.2 Europe CAR T-cell Therapy Landscape Analysis by Major End-Users

    • 8.3 Europe CAR T-cell Therapy Landscape Analysis by Top Countries

      • 8.3.1 Germany CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.2 UK CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.3 France CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.4 Italy CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.5 Spain CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.6 Belgium CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.7 Poland CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.8 Russia CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.9 Turkey CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.10 Netherlands CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.11 Portugal CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.12 Denmark CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.13 Finland CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.14 Iceland CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.15 Norway CAR T-cell Therapy Market Volume and Growth Rate

      • 8.3.16 Sweden CAR T-cell Therapy Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific CAR T-cell Therapy Landscape Analysis

    • 9.1 Asia Pacific CAR T-cell Therapy Landscape Analysis by Top Countries

      • 9.1.1 China CAR T-cell Therapy Market Volume and Growth Rate

      • 9.1.2 Japan CAR T-cell Therapy Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) CAR T-cell Therapy Market Volume and Growth Rate

      • 9.1.4 India CAR T-cell Therapy Market Volume and Growth Rate

      • 9.1.5 ASEAN CAR T-cell Therapy Market Volume and Growth Rate

      • 9.1.6 South Korea CAR T-cell Therapy Market Volume and Growth Rate

    10 LAMEA CAR T-cell Therapy Landscape Analysis

    • 10.1 LAMEA CAR T-cell Therapy Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries CAR T-cell Therapy Market Volume and Growth Rate

      • 10.1.2 Brazil CAR T-cell Therapy Market Volume and Growth Rate

      • 10.1.3 North Africa CAR T-cell Therapy Market Volume and Growth Rate

      • 10.1.4 South Africa CAR T-cell Therapy Market Volume and Growth Rate

      • 10.1.5 Argentina CAR T-cell Therapy Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Legend Biotech

      • 11.1.1 Legend Biotech Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Pfizer, Inc.

      • 11.2.1 Pfizer, Inc. Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Celyad, Inc.

      • 11.3.1 Celyad, Inc. Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Bluebird Bio, Inc.

      • 11.4.1 Bluebird Bio, Inc. Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Aurora BioPharma, Ltd.

      • 11.5.1 Aurora BioPharma, Ltd. Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Kite Pharma, Inc.

      • 11.6.1 Kite Pharma, Inc. Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Celgene (Juno Therapeutics) Inc.

      • 11.7.1 Celgene (Juno Therapeutics) Inc. Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Juno Therapeutics

      • 11.8.1 Juno Therapeutics Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Aurora BioPharma, Ltd.

      • 11.9.1 Aurora BioPharma, Ltd. Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Aurora Biopharma Inc.

      • 11.10.1 Aurora Biopharma Inc. Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Allogene Therapeutics International AGech

      • 11.11.1 Allogene Therapeutics International AGech Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Bluebird Bio, Inc.

      • 11.12.1 Bluebird Bio, Inc. Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 128 Figures and 112 Tables)

    • Figure Product Picture

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of CD 19 from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of CD 20 from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of CD22 from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of CD30 from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of CD33 from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of HER1 from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of HER2 from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of Meso from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of Egfrvlll from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of Acute Lymphocytic Leukemia from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of Chronic Lymphocytic Leukemia from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of Non Hodgkin Leukemia from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of Multiple Myeloma from 2014 to 2026

    • Figure Global CAR T-cell Therapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

    • Figure North America CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure United States CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Canada CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Europe CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Germany CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure UK CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure France CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Italy CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Spain CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Poland CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Russia CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure China CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Japan CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Australia CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure India CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure GCC CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina CAR T-cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of CAR T-cell Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of CAR T-cell Therapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of CAR T-cell Therapy by Different Types from 2014 to 2026

    • Table Consumption Share of CAR T-cell Therapy by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of CD 19

    • Figure Market Size and Growth Rate of CD 20

    • Figure Market Size and Growth Rate of CD22

    • Figure Market Size and Growth Rate of CD30

    • Figure Market Size and Growth Rate of CD33

    • Figure Market Size and Growth Rate of HER1

    • Figure Market Size and Growth Rate of HER2

    • Figure Market Size and Growth Rate of Meso

    • Figure Market Size and Growth Rate of Egfrvlll

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of CAR T-cell Therapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of CAR T-cell Therapy by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Acute Lymphocytic Leukemia

    • Figure Market Size and Growth Rate of Chronic Lymphocytic Leukemia

    • Figure Market Size and Growth Rate of Non Hodgkin Leukemia

    • Figure Market Size and Growth Rate of Multiple Myeloma

    • Figure Market Size and Growth Rate of Pancreatic Cancer

    • Table Global CAR T-cell Therapy Production by Major Regions

    • Table Global CAR T-cell Therapy Production Share by Major Regions

    • Table Global CAR T-cell Therapy Consumption by Major Regions

    • Table Global CAR T-cell Therapy Consumption Share by Major Regions

    • Table North America CAR T-cell Therapy Production, Import, Consumption and Export Analysis

    • Table Europe CAR T-cell Therapy Production, Import, Consumption and Export Analysis

    • Table Asia Pacific CAR T-cell Therapy Production, Import, Consumption and Export Analysis

    • Table LAMEA CAR T-cell Therapy Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in CAR T-cell Therapy Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in CAR T-cell Therapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in CAR T-cell Therapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in CAR T-cell Therapy Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America CAR T-cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table North America CAR T-cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure North America CAR T-cell Therapy Consumption Share by Major Countries in 2014

    • Figure North America CAR T-cell Therapy Consumption Share by Major Countries in 2018

    • Figure North America CAR T-cell Therapy Consumption Share by Major Countries in 2026

    • Figure United States CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Europe CAR T-cell Therapy Consumption by Types from 2014 to 2026

    • Table Europe CAR T-cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Europe CAR T-cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Europe CAR T-cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Europe CAR T-cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Europe CAR T-cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure UK CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure France CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific CAR T-cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific CAR T-cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure China CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure India CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa CAR T-cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa CAR T-cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries CAR T-cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Legend Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Legend Biotech

    • Figure Sales and Growth Rate Analysis of Legend Biotech

    • Figure Revenue and Market Share Analysis of Legend Biotech

    • Table Product and Service Introduction of Legend Biotech

    • Table Company Profile and Development Status of Pfizer, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc.

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc.

    • Figure Revenue and Market Share Analysis of Pfizer, Inc.

    • Table Product and Service Introduction of Pfizer, Inc.

    • Table Company Profile and Development Status of Celyad, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celyad, Inc.

    • Figure Sales and Growth Rate Analysis of Celyad, Inc.

    • Figure Revenue and Market Share Analysis of Celyad, Inc.

    • Table Product and Service Introduction of Celyad, Inc.

    • Table Company Profile and Development Status of Bluebird Bio, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bluebird Bio, Inc.

    • Figure Sales and Growth Rate Analysis of Bluebird Bio, Inc.

    • Figure Revenue and Market Share Analysis of Bluebird Bio, Inc.

    • Table Product and Service Introduction of Bluebird Bio, Inc.

    • Table Company Profile and Development Status of Aurora BioPharma, Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurora BioPharma, Ltd.

    • Figure Sales and Growth Rate Analysis of Aurora BioPharma, Ltd.

    • Figure Revenue and Market Share Analysis of Aurora BioPharma, Ltd.

    • Table Product and Service Introduction of Aurora BioPharma, Ltd.

    • Table Company Profile and Development Status of Kite Pharma, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma, Inc.

    • Figure Sales and Growth Rate Analysis of Kite Pharma, Inc.

    • Figure Revenue and Market Share Analysis of Kite Pharma, Inc.

    • Table Product and Service Introduction of Kite Pharma, Inc.

    • Table Company Profile and Development Status of Celgene (Juno Therapeutics) Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene (Juno Therapeutics) Inc.

    • Figure Sales and Growth Rate Analysis of Celgene (Juno Therapeutics) Inc.

    • Figure Revenue and Market Share Analysis of Celgene (Juno Therapeutics) Inc.

    • Table Product and Service Introduction of Celgene (Juno Therapeutics) Inc.

    • Table Company Profile and Development Status of Juno Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics

    • Figure Sales and Growth Rate Analysis of Juno Therapeutics

    • Figure Revenue and Market Share Analysis of Juno Therapeutics

    • Table Product and Service Introduction of Juno Therapeutics

    • Table Company Profile and Development Status of Aurora BioPharma, Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurora BioPharma, Ltd.

    • Figure Sales and Growth Rate Analysis of Aurora BioPharma, Ltd.

    • Figure Revenue and Market Share Analysis of Aurora BioPharma, Ltd.

    • Table Product and Service Introduction of Aurora BioPharma, Ltd.

    • Table Company Profile and Development Status of Aurora Biopharma Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurora Biopharma Inc.

    • Figure Sales and Growth Rate Analysis of Aurora Biopharma Inc.

    • Figure Revenue and Market Share Analysis of Aurora Biopharma Inc.

    • Table Product and Service Introduction of Aurora Biopharma Inc.

    • Table Company Profile and Development Status of Allogene Therapeutics International AGech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allogene Therapeutics International AGech

    • Figure Sales and Growth Rate Analysis of Allogene Therapeutics International AGech

    • Figure Revenue and Market Share Analysis of Allogene Therapeutics International AGech

    • Table Product and Service Introduction of Allogene Therapeutics International AGech

    • Table Company Profile and Development Status of Bluebird Bio, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bluebird Bio, Inc.

    • Figure Sales and Growth Rate Analysis of Bluebird Bio, Inc.

    • Figure Revenue and Market Share Analysis of Bluebird Bio, Inc.

    • Table Product and Service Introduction of Bluebird Bio, Inc.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.